Paul Wolstenholme-Hogg
SynZyme Technologies (United States)(US)
Publications by Year
Research Areas
Cystic Fibrosis Research Advances, Asymmetric Synthesis and Catalysis, Neonatal Respiratory Health Research, Coordination Chemistry and Organometallics, Organometallic Complex Synthesis and Catalysis
Most-Cited Works
- → Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial(2015)420 cited
- → A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis(2016)45 cited
- → Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody–drug conjugates(2012)33 cited
- → In vivo imaging of gene transfer to the respiratory tract(2007)14 cited
- → Synthetic Studies on Formamidopyrimidines Related to Clofarabine(2008)2 cited
- → Chapter 3. Organometallic chemistry . Part (i) Palladium and nickel catalysed methods(1998)2 cited
- Safety and adverse events(2016)
- Patient information sheets(2016)
- → ChemInform Abstract: Organometallic Chemistry. Part 1. Palladium‐ and Nickel‐Catalyzed Methods(1999)
- Dose preparation sheet(2016)